The current hardening insurance market is driving greater interest in self-insurance via a captive and leading to a cooling of relations between companies and their insurers. AMRAE president Oliver Wild told Captive International sister publication Intelligent Insurer why insurers need to have a rethink—and talk to risk managers.
In the first in a new series of video interviews with key individuals in the captive insurance industry, Captive International spoke to James Larkin, head of business development for captive insurance at Barclays.
Evidence of the wisdom of crowds is all around us, from Google searches to market prices. The same principle is at work with group captives, says Greg Lang of the Reinsurance and Insurance Network in the fourth and final piece in a series on the future of work.
Mexico’s use of captives is increasing despite the lack of specific captive insurance legislation, and new laws may be not far off, say Thomas Morante and Yani Contreras of Carlton Fields.
Christine Hougaard and Matthew Dunn of Cenfri, and Ernie van der Vyver from Clyde & Co examine the lessons that can be learned from South Africa’s cell captive regulatory journey.
Businesses are seeing costs escalate, not least in the form of rising medical costs. Using a captive as a centralised risk management tool for employee benefits can help reduce these costs by enabling a comprehensive approach to global risk financing, say Aon’s Aidan Kelly and Vaibhavi Patel.
The COVID-19 pandemic has taken a heavy toll on Compass Group, the contract catering business. When the virus struck the company was in the process of overhauling its insurance and risk management strategy, and now an enhanced role for its captives may position it well for future challenges. Captive International spoke to Compass Group's Scott Feltham.
The future looks bright for the Asian captive insurance market in 2021, with at least three domiciles offering attractive captive regimes despite the possibility that 2020 will be lost to the COVID-19 pandemic. Adrian Halter, Bernard Yap, Ji Yao, Ming Lam and Shen Mei Soh of EY examine the outlook for the Asian market.
Having a captive has been transformational for GSK’s health and wellbeing strategy, allowing it to redirect medical spend to the most appropriate areas through data-driven targeted intervention, says the firm’s Anthony Tropea.
Investing in an index implies a high degree of diversification, but in fact weighting by market capitalisation means indexes such as the S&P 500 are dominated by their largest stocks, to a quite surprising degree, as Jack Meskunas of Oppenheimer explains.